Heterocyclic compound
US8722660B2 · kind B2 · utility
1Cited by
4References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 16, 2011 |
| Grant date | May 13, 2014 |
| Priority date | — |
| Expiry date | Feb 16, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a compound useful for the prophylaxis or treatment of cancer.The present invention relates to a compound represented by formula (I):wherein each symbol in the formula is as defined in the specification, or a salt thereof or a prodrug thereof, which is useful for the prophylaxis or treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.